Form 4: Elanco CFO Acquires Deferred Stock Units Under 10b5-1 Plan

Elanco Animal Health's EVP and CFO, Robert M. VanHimbergen, acquired 7.8029 deferred stock units as part of a pre-arranged plan.

Summary

• Robert M. VanHimbergen, EVP and CFO of Elanco Animal Health Inc., acquired 7.8029 Deferred Stock Units (DSUs) on January 23, 2026.
• Each DSU represents the right to receive one share of company common stock or its cash equivalent.
• This transaction was made pursuant to a Rule 10b5-1(c) plan, indicating a pre-arranged trading plan.
• The DSUs are scheduled to settle in cash or shares of common stock following termination of employment or during a specified future year, as per the Executive Deferral and Stock Match Plan.
• Following this acquisition, VanHimbergen beneficially owns a total of 15.915 Deferred Stock Units.
• The derivative security was valued at $24.4 per unit.

Sentiment

Score: 6

Explanation: The acquisition of deferred stock units by a key executive, even if part of a pre-arranged plan, generally signals management's long-term commitment and alignment with shareholder interests, contributing to a moderately positive sentiment.

Positives

• The acquisition of deferred stock units by a key executive (CFO) can signal confidence in the company's future performance and alignment with shareholder interests.
• The transaction was made under a Rule 10b5-1(c) plan, indicating a pre-arranged, non-discretionary transaction, which enhances transparency.

Negatives

• The transaction involves deferred stock units, not a direct cash purchase of common stock by the executive, meaning no immediate personal capital is at risk.

Risks

• The future value of the deferred stock units is directly tied to the market performance of Elanco Animal Health Inc.'s common stock.

Future Outlook

Deferred Stock Units will settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with the Executive Deferral and Stock Match Plan.

Industry Context

This filing is an insider transaction report, which provides insight into executive compensation and equity ownership, rather than broader industry trends or competitive positioning.

Corporate Governance

Related Party Transactions

• Acquisition of deferred stock units by the EVP and CFO as part of an executive deferral and stock match plan, which is a standard form of executive compensation.

Stakeholder Impact

• Shareholders: Potential positive signal of management's long-term commitment and alignment with shareholder interests.
• Employees: Reflects the structure of executive compensation within the company.

Next Steps

• Settlement of Deferred Stock Units in cash or shares of common stock upon termination of employment or during a specified future year, as per the Executive Deferral and Stock Match Plan.

Key Dates

Recommendation

This Form 4 filing reports a routine executive compensation event involving a small number of deferred stock units granted to the CFO under a pre-arranged plan. While it indicates executive alignment, the transaction volume is not significant enough to alter the fundamental investment thesis or warrant a change in the current investment recommendation.

Keywords

Elanco Animal Health, ELAN, Form 4, Insider Transaction, Deferred Stock Units, Executive Compensation, Robert M. VanHimbergen, CFO, Rule 10b5-1